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ABSTRACT
We developed a framework for quick and reliable
construction of complex gene circuits for genetic-
ally engineering mammalian cells. Our hierarchical
framework is based on a novel nucleotide address-
ing system for defining the position of each part in
an overall circuit. With this framework, we demon-
strate construction of synthetic gene circuits of up
to 64kb in size comprising 11 transcription units and
33 basic parts. We show robust gene expression
control of multiple transcription units by small
molecule inducers in human cells with transient
transfection and stable chromosomal integration
of these circuits. This framework enables develop-
ment of complex gene circuits for engineering mam-
malian cells with unprecedented speed, reliability
and scalability and should have broad applicability
in a variety of areas including mammalian cell fer-
mentation, cell fate reprogramming and cell-based
assays.
INTRODUCTION
The ability to introduce into mammalian cells genetic
circuits that contain multiple transcription units (TUs) is
of great interest for a variety of applications including
biotechnology (1), gene therapy (2), systems/synthetic
biology (3) and reprogramming cell fate and functions
(4), as well as basic biological research (5). Encoding
such multi-TU gene circuits on single vectors offers
several advantages over using separate vectors (6,7), for
example, to improve correlation in gene expression
between the different circuit elements and for an integra-
tion of the entire circuit into a single genomic locus.
However, the construction of such large single-vector
circuits is challenging because of long and/or repetitive
sequences and the need for genetic elements that impart
robust expression in mammalian cells. Existing DNA
assembly methods are often not well suited for
manipulating large collections of mammalian sequences.
For example, methods that rely on the use of Type IIs
restriction enzymes (8) can be problematic because these
restriction sites occur frequently in mammalian promoters
and genes. Other methods require multiple rounds of
cloning (6,9), cloning in yeast (10) or polymerase chain
reaction (PCR) (7). With PCR, the precision of even
high-ﬁdelity polymerases is insufﬁcient for reliable
and error-free large-scale ampliﬁcation (Supplementary
Table S1). Furthermore, multi-TU gene circuits lacking
insulating elements suffer from transcriptional interfer-
ence and are signiﬁcantly hampered in their function
(11). To address these issues, we developed a new frame-
work for quick and reliable assembly of functional
complex mammalian gene circuits. Here, we describe in
detail the components, steps and mechanisms underlying
the framework. We demonstrate efﬁcient and robust con-
struction of circuits with various sizes and number of
assembled parts, and show that assembly works well
despite repetitive sequences present in some of the parts.
The resulting gene circuits were functionally assessed in
transfection as well as stable genomic integration and
behaved according to their predicted phenotypes. The
framework described here can also prove to be valuable
for building large-scale mammalian genetic module
libraries, and is well suited for generation of stable cell
lines with multielement circuits.
MATERIALS AND METHODS
Strains
Escherichia coli 10G (Lucigen Corp., Middletown, WI,
USA) were used for most cloning steps except for the
pJazz-based and the bacterial artiﬁcial chromosome
(BAC)-based carrier vectors. pJazz/BigEasy v2.0 Linear
Cloning System and pSMART-BAC (Lucigen Corp.)
were purchased and used according to their manual in
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their respective strains (BigEasy TSA and BAC-Optimized
Replicator v2.0). Antibiotic was used with following con-
centrations: 100 mg/ml Ampicillin, 50 mg/ml Kanamycin,
25 mg/ml Chloramphenicol. Gel extraction was done with
the Qiagen QIAquick Gel Extraction Kit. PCR puriﬁ-
cation was done using the Qiagen QIAquick PCR
Puriﬁcation Kit. Miniprepping of DNA was done using
the Qiagen Qiaprep Spin Miniprep Kit. Some minipreps
were automated on a Qiagen Qiacube using the same
miniprep kit.
Library of genes and promoters
The Gateway BP reaction was performed according to the
manufacturer’s manual (Life technologies, Carlsbad, CA,
USA). Brieﬂy, to create the promoter library, the
promoter sequences of interest were ampliﬁed, digested
and inserted into pENTR_L4_R1 that was cut with com-
patible restriction enzymes. To create the gene library, the
gene of interest was ampliﬁed with attB1-site in the
forward primer and attB2-site in the reverse primer. Ten
femtomoles of the PCR product was mixed with 5 fmol of
pDONR221P1P2 and incubated with 1 ml of BP clonase II
(11789-020, Life technologies) for 1 h. One microliter of
the reaction was transformed into ccdB sensitive compe-
tent E. coli cells. Alternatively, the gene sequences of
interest were ampliﬁed, digested and inserted into
pENTR_L1_L2 cut with compatible restriction enzymes.
Gateway LR reaction
Gateway LR reactions were performed according to the
manufacturer’s manual (Life technologies, Carlsbad).
Brieﬂy, 5 fmol of each of pENTR_L4_R1,
pENTR_L1_L2 and pZDonor_Seq(n)-GTW-Seq(n+1)
that contains Gateway cassette of pDEST_R4_R2 were
mixed and incubated with 1 ml of LR clonase II mix
(11971-020, Life technologies) for 16 h. One microliter of
the reaction was transformed into ccdB sensitive compe-
tent E. coli cells.
Digestion of vectors containing the basic assembly units
Seventy femtomoles of each vector containing a basic
assembly unit were pooled and digested in a total
volume of 20 ml for 6 h using 10U of the restriction
enzyme I-SceI (R0694, NEB Biolabs, MA, USA).
Subsequently, this digest was puriﬁed using the
QIAGEN Qiaquick PCR puriﬁcation kit and eluted in
30 ml of warm Tris-EDTA (TE) buffer. Alternatively, the
I-SceI digest was heat-inactivated (65C, 20min) and used
without further puriﬁcation.
Digestion of the adaptor vector
Two hundred eighty femtomoles of the adaptor vector
required for proper circuit closure was digested in a
total volume of 20 ml with 10U each of restriction
enzymes XbaI and XhoI (R0146, R0145, NEB Biolabs)
for 3 h, puriﬁed using the QIAGEN Qiaquick PCR puri-
ﬁcation kit and eluted in 30 ml of warm TE buffer.
Alternatively, the digest was heat-inactivated (65C,
20min) and used without further puriﬁcation.
Digestion of the carrier vector
One hundred forty femtomoles of the carrier vector was
digested in a total volume of 20 ml with 4U of the restric-
tion enzyme FseI or PacI (R0588, R0547 NEB Biolabs)
for 3 h, puriﬁed using the QIAGEN Qiaquick PCR puri-
ﬁcation kit and eluted in 30 ml of warm TE buffer.
Alternatively, the digest was heat-inactivated (65C,
20min) and used without further puriﬁcation.
One-step assembly using exonuclease, ligase and
polymerase (Gibson Reaction)
The reaction buffer was made according to Gibson’s
original recipe (12). Brieﬂy, isothermal reaction buffer
(IRB) was prepared on ice and stored at 20C: 25%
PEG-8000, 500mM Tris–HCl, pH 7.5, 50mM MgCl2,
50mM dithiothreitol (DTT), 1mM each of dATP,
dCTP, dGTP and dTTP and 5mM NAD. Assembly
Master Mix was prepared on ice and stored at 20C:
320 ml IRB buffer, 0.64ml of 10U/ml T5 exonuclease
(T5E4111K, Epicentre Biotechnologies, WI, USA), 20 ml
of 2U/ml Phusion polymerase (F-530, NEB Biolabs),
160 ml of 40 U/ml Taq ligase (M0208, NEB Biolabs),
deionized water to a 1.2ml total volume. Seven
femtomoles of each part (digested adaptor vector,
digested carrier vector and digested pool of assembly
units) were combined in a 200 ml PCR reaction tube on
ice and ﬁlled up to a 5 ml of total volume with deionized
water. The mix was then added to 15 ml of the Assembly
Master Mix, and the reaction was incubated at 50C for
1 h. This reaction (2–5 ml) was then transformed into com-
petent E. coli cells.
Hierarchical assembly
The assembly units and the adaptor were assembled into
the hierarchical pJazz carrier vector. One hundred forty
femtomoles of assembled vector was digested in total
volume of 20 ml for 6 h using 10U of the restriction
enzyme I-SceI. Seven femtomoles of this digest was
combined with 7 fmol of each additional part (digested
adaptor vector, digested carrier vector and digested pool
of assembly units). Kanamycin resistance adaptor and
Tetracycline resistance adaptors were used in an
alternating manner. A one-step assembly protocol was
applied on this mixture.
Cell culture
HEK293FT (Invitrogen, Carlsbad, CA, USA) cells were
cultured in supplemented Dulbecco’s modiﬁed Eagle’s
medium according to their manual. Chemical DNA trans-
fection was performed using Qiagen SuperFect
Transfection Reagent (QIAGEN, Hilden, Germany) or
Metafectene Pro (Biontex, Martinsried, Germany). In
brief, 800 000 cells were seeded into a 10-cm2 well and
immediately transfected with 2 mg of DNA. The medium
was replaced 6 h after transfection. To induce the Tet-On
system, Doxycycline (Clontech, Mountain View, CA,
USA) was added to culture media at 1 mg/ml. To induce
the Rheo system, Genostat ligand (EMD Millipore,
Burlington, MA, USA) was added to the cell culture at
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a ﬁnal concentration of 5 nM. Targeted integration into
the AAVS1 locus: The carrier vector was stably integrated
(13) into the chromosome of HEK293 cells and stable
clones were selected with 1 mg/ml of Puromycin (Xavier
Duportet et al., submitted for publication).
Microscope imaging
Images were taken using a Leica TCS SP5 II 405UV
confocal microscope (Leica Microsystems, Bannockburn,
IL, USA). Images were acquired using a sequential scan.
First scan: excitation/laser lines: 488 nm, emission: 495–
539 nm; second scan: excitation/laser lines: 458 and
543 nm, emission: 462–487 and 547–800 nm, respectively.
Flow cytometry measurement
Flow cytometry measurement was carried out on BD LSR
II in Koch Institute Flow Cytometry Core at MIT. Data
were collected in BD FACSDiva software and analyzed in
Flowjo (Tree Star, Inc. Ashland, OR, USA)
Algorithms
The algorithm and parameters for designing the unique
oligonucleotide sequences are detailed in Supplementary
Method.
RESULTS
Genetic circuit design and construction
Our assembly method integrates multisite Gateway re-
combination, Gibson assembly (12) and a nucleotide-
addressing system for deﬁning the position of every part
in the ﬁnal overall vector (Figure 1a). First, the user
chooses promoter/gene pairs from a sequence-veriﬁed
library of parts and then determines the circuit position
of each of these TUs by Gateway recombination with an
appropriate customized Gateway destination vectors. The
resulting vectors, called position vectors, contain nucleo-
tide sequences that specify the position of each TU in the
ﬁnal circuit vector. Position vectors are veriﬁed by restric-
tion mapping (>90% usually correct) (15), and then
digested and assembled together with a carrier vector
and an adaptor vector using a Gibson reaction to form
the ﬁnal vector. Our customized Gateway destination
vectors contain (from 50 to 30) an I-SceI restriction site, a
unique nucleotide sequence (UNS), a tandem repeat of the
core cHS4 chromatin insulator (16), a Gateway recom-
bination cassette, a polyadenylation sequence, another
UNS and another I-SceI restriction site (Figure 1a,
Supplementary Figure S1a). The I-SceI recognition sites
and UNSs form the core of the nucleotide-addressing
system. Digesting the position vector with I-SceI releases
the TU ﬂanked by the two UNSs. The TU should not
contain the 18-bp I-SceI site, but the likelihood of this
sequence being present in a TU is small—neither the
mouse genome nor the human genomes contain this rec-
ognition site. UNSs comprise a series of 40-bp nucleotide
sequences that are designed using a computational algo-
rithm to maximize the probability of annealing to the
complementary UNS during the Gibson reaction and
to minimize hairpin formation when exposed as sin-
gle-stranded DNA (Supplementary Figure S1b, algorithm
described in Supplementary Methods). Chromatin insula-
tor and polyadenylation sequences are included in each
position vector for robust mammalian gene expression.
Once assembled, chromatin insulators from adjacent
assembled transcriptional units form insulation pairs
that are used to dampen crosstalk by transcriptional regu-
lators (11) as well as the spreading of genomic silencing
(17). The carrier vector contains sequences necessary for
propagation in E. coli as well as UNS 1 and X, where
UNS X is used to link the last TU in the circuit to the
carrier vector. Additional genetic elements, for instance
episomal sequences or genomic recombination sites, can
be added to the carrier vector to obtain other desired func-
tionality. To link the last position vector to the carrier
vector at UNS X, an adaptor vector is chosen from an
adaptor library. The adaptor also provides a second selec-
tion marker (e.g. Kanamycin or Tetracycline) to select
against empty vector backbones during Gibson
assembly. For example, a 5-TU gene circuit can be
assembled from position vectors with UNS pairs 1–2, 2–
3, 3–4, 4–5 and 5–6 and an adaptor vector containing
UNS 6–X (Figure 1a). A list of components available as
part of the platform is available in Supplementary Table
S2. To facilitate gel electrophoresis analysis of the large
gene circuits, we developed an algorithm to create high-
resolution restriction maps (Supplementary Figure S2, re-
striction map algorithm described in Supplementary
Method S2).
Assembly method efﬁciency
We demonstrate the efﬁciency of our method by
assembling >30 basic parts into single vectors (Figure 1c
and d and Supplementary Figure S2). The entire construc-
tion process from basic parts (promoters, genes) to a
transfection- or integration-ready circuit vector requires
<5 days with a workload of a few hours a day
(Figure 1b). Starting from preexisting TUs, construction
takes only 2 days. Figure 1c shows the percentage of bac-
terial colonies that contained the correct circuits for
assemblies of up to 33 basic parts and a ﬁnal vector size
of 64 kb. Our data suggest that for assemblies with <21
parts or 7 TUs, it is usually sufﬁcient to screen only two
colonies (<10% probability of both colonies not contain-
ing the correct circuit, Figure 1b).
Reliable, robust expression and exogenous control
We assayed the behavior in mammalian cells of large gene
circuits constructed with our method. A 39-kb vector con-
taining a 7-TU circuit that was assembled into a BAC
carrier vector (Figure 2a and restriction digest/analysis
in Supplementary Figure S2), exhibited robust gene
expression on induction with Doxycycline and/or
Rheo ligand when transfected into HEK293FT cells
(Figure 2a). We also compared gene expression from a
single transfected plasmid to gene expression from three
co-transfected plasmids that contain the same circuit
elements. The circuit comprises constitutive expression
of Enhanced Blue Fluorescent Protein (EBFP),
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Enhanced Yellow Fluorescent Protein (EYFP) and a
reverse tetracycline transactivator (rtTA3) and
Doxycycline-inducible mKate (Figure 2b). EYFP serves
as a transfection marker. The results show that having
the entire circuit in a single plasmid signiﬁcantly reduces
EBFP and mKate variance over a wide range of transfec-
tion levels, based on ﬂow cytometry analysis
(Supplementary Figure S3). To determine if circuits
assembled with this framework perform well with stable
chromosomal integration, we integrated the above 3-TU
circuit into the AAVS1 locus of HEK293FT cells and
quantiﬁed the resulting ﬂuorescence. After 17 days,
>85% of polyclonal cells co-expressed EBFP and EYFP
with similar levels of expression and 87% of these EBFP-
EYFP double-positive cells expressed mKate in an indu-
cible manner (Figure 2c and d).
Hierarchical circuit assembly
Our method supports hierarchical assembly of gene
circuits (Supplementary Figure S4). Hierarchical con-
struction and reuse of genetic modular circuits should
facilitate design and implementation of high-order gene
circuits and larger systems (18). With this approach to
Figure 1. Overview of the DNA assembly process and its efﬁciency. (a) Schematics of the assembly process. For every TU, the chosen promoter,
gene and destination vector are recombined using the Gateway LR reaction. The UNS in the destination vector determines the TU’s position within
the gene circuit. The resulting position vectors are pooled, digested with I-SceI and combined with equimolar amounts of predigested carrier vector
and adaptor vector. The Gibson reaction mix exposes the UNS, permitting annealing, extension and ligation to form a single large vector (pCircuit).
pCircuit itself can be reused for a further round of assemblies by digesting it with I-SceI, freeing the 5-TU circuit ﬂanked by the UNS 1 and 2.
(b) Timeline and steps for circuit assembly starting from libraries of parts. If all TUs are already available, the assembly process starts from day 3
and takes 2 days to ﬁnish. The approximate hours of benchwork needed each day is indicated in the bottom row (h=hours). (c) TUs were
assembled into a linear carrier vector (customized pJazz) (14). The percentage reﬂects the number of colonies containing the correct vector vs. the
number of analyzed colonies. Size in kilobases is the average size (multiple different circuits tested per # of parts) (d) Accuracy of the assembly
process for a 7-TU circuit. Asterisk: correct restriction digest.
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the creation of sophisticated systems, one can ﬁrst
assemble and verify simpler modules (e.g. bistable
switches, cascades, biosynthesis pathways, etc.) and also
obtain such modules from other sources, before proceed-
ing to the construction of the complete systems.
Recently, a plug-and-play method (19) based on restric-
tion enzymes was developed that supports reuse and
repurposing of existing genetic circuits for the construc-
tion of new bacterial synthetic gene networks. In our
framework, each assembled circuit vector contains an
I-SceI site upstream of the vector’s 50 UNS 1 and an
I-SceI site downstream of UNS 2 at the 30-end
(Figure 1a). Digestion with I-SceI creates a position
1–2 vector piece that can be assembled with other pos-
ition vectors and an appropriate adaptor vector. Two
different adaptor vectors, containing either Kanamycin
or Tetracycline resistance, are used in an alternating
fashion to select against the parental modules. To dem-
onstrate recursive assembly of gene circuits, we ﬁrst
designed and built a 7-TU, 45-kb module. The module
contains three inducible promoters and four constitutive
promoters expressing inducible regulators, selection
markers and ﬂuorescent reporters. After constructing
this module, we then used it to create a larger 12-TU
circuit (36 parts, 63 kb, Supplementary Figure S4). The
additional 5 TUs that were added in the second step
include parts that are already present in the 7-TU
circuit, allowing us to determine whether our hierarchical
assembly method is robust to repetitive sequences, and
indeed the construction was successful (Supplementary
Figure S4).
DISCUSSION
The framework described here for assembling complex
genetic circuits uses readily available reagents and
enzymes and is reliable, efﬁcient, modular and supports
a hierarchical construction scheme. We assemble large and
complex gene and demonstrate robust regulation of gene
expression within these multigene circuits using small
molecule inducers in human cells with both transient
transfection and stable chromosomal integration. The
assembly of repetitive sequences (e.g. multiple repeats of
the same promoter or gene) did not result in undesirable
recombination events or genetic stability issues (conﬁrmed
by sequencing, data not shown). Because our framework
does not rely on restriction enzymes, it is highly ﬂexible
and can be used for assembly of components constructed
using other cloning methods, (e.g. Golden Gate assembly).
Also, gene circuit modules with specialized functions can
be validated and stored separately, and combined when
needed based on hierarchical system design, yielding large
Figure 2. Gene circuit function in mammalian cells. (a) Microscope images from transfection of a 7-TU, 39-kb gene circuit. The circuit constitutively
expresses nuclear-localized ECFP, nuclear-localized mKate, rtTA3, RheoAct/RheoRec and Blasticidin. On addition of Doxycycline, expression of
membrane-localized mKate2 is induced. EYFP is expressed on addition of Genostat ligand. Chrom. ins., chromatin insulator. Scale bar: 20 mm (b) A
3-TU, 17-kb gene circuit that was stably integrated into HEK293FT cells. (c) Flow cytometry dot-plots for cells not containing the circuit (Control),
and cells containing the chromosomally integrated circuit with or without Doxycycline (±Dox). (d) Assessing the functionality of the gene circuit
described in (b). Percentage of cells expressing EYFP and EBFP in (ﬁrst column) total population, (second column) EYFP or EBFP expressing
population and (third column) percentage of cells expressing mKate in EYFP and EBFP double-positive cells on addition of Doxycycline.
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circuits with complex phenotypes. We anticipate that our
approach will be valuable for building large-scale gene
circuit libraries with reliable gene expression, and will be
suitable for the generation of stable cell lines with func-
tional multielement circuits. This will greatly beneﬁt the
rapidly growing ﬁeld of mammalian synthetic biology as
well as facilitate genetic engineering of mammalian cells
with complex multigene circuits. The method described
here is not restricted to mammalian cell engineering. By
extending the library of parts (genes, promoters) and ap-
propriate modiﬁcations of inter-TU regions, the approach
can support rapid genetic engineering of many other
organisms.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online,
including [20–27].
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